Researchers develop messenger RNA therapy for ovarian cancer, muscle wasting
Researchers at Oregon State University and Oregon Health & Science University have developed a promising, first-of-its-kind messenger RNA therapy for ovarian cancer as well as cachexia, a muscle-wasting condition associated with cancer and other chronic illnesses. The treatment is based on the same principles used in SARS-CoV-2 vaccines, and the scientists say mRNA technology, though …